Insider Transactions in Q2 2021 at Aprea Therapeutics, Inc. (APRE)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Jun 30 2021	Fouad Namouni Director	BUY Grant, award, or other acquisition	Direct	4,610 +50.0%	-
Jun 30 2021	Bernd R. Seizinger Director	BUY Grant, award, or other acquisition	Direct	4,610 +1.69%	-
Jun 30 2021	Richard Peters Director	BUY Grant, award, or other acquisition	Direct	4,610 +50.0%	-
Jun 30 2021	Michael Aaron Kelly Director	BUY Grant, award, or other acquisition	Direct	4,610 +50.0%	-
Jun 30 2021	John B Henneman Iii Director	BUY Grant, award, or other acquisition	Direct	4,610 +32.42%	-

Receive a notification when an Institution or Guru buys or sells APRE shares.

Notify only if

Value

Get notified when an Aprea Therapeutics, Inc. insider buys or sells APRE shares.

Notify only if

Operation

Value

Type

Receive news related to Aprea Therapeutics, Inc.